Lethal varicella-zoster virus reactivation without skin lesions following renal transplantation

Nephrology Dialysis Transplantation

Volumn 26, Issue 1, 2011, Pages 365-368

  Jantsch, Jonathan ^a   Schmidt, Barbara ^b   Bardutzky, Jürgen ^c   Bogdan, Christian ^a   Eckardt, Kai Uwe ^c   Raff, Ulrike ^c  

^a Clinical Microbiology Immunology and Hygiene   (Switzerland)

^b Inst of Clin and Molec Virology   (Germany)

^c UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

renal transplantation; varicella zoster reactivation

Indexed keywords

ACICLOVIR; AZATHIOPRINE; HALOPERIDOL; PREDNISOLONE; PREDNISONE; RITUXIMAB; TACROLIMUS; THYMOCYTE ANTIBODY;

AGED; ARTICLE; ARTIFICIAL VENTILATION; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; COORDINATION DISORDER; EXTRAPYRAMIDAL SYMPTOM; FEMALE; HERPES ZOSTER ENCEPHALITIS; HUMAN; IMMUNOADSORPTION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; MUSCLE TONE; PNEUMONIA; PRIORITY JOURNAL; RESPIRATORY FAILURE; SCHIZOIDISM; SOMNOLENCE; TREMOR; VARICELLA ZOSTER VIRUS; VIRUS REACTIVATION;

AGED; ANTIVIRAL AGENTS; FEMALE; HERPES ZOSTER; HERPESVIRUS 3, HUMAN; HUMANS; KIDNEY TRANSPLANTATION; MENINGOENCEPHALITIS; PROGNOSIS; SKIN DISEASES; VIRUS ACTIVATION;

EID: 78650637032     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfq542     Document Type: Article

References (13)

1. Miller GG, Dummer JS. Herpes simplex and varicella zoster viruses: forgotten but not gone. Am J Transplant 2007; 7: 741-747
2. Weinberg A, Zhang JH, Oxman MN et al. Varicella-zoster virus-specific immune responses to herpes zoster in elderly participants in a trial of a clinically effective zoster vaccine. J Infect Dis 2009; 200: 1068-1077
3. Peterson LR, Ferguson RM. Fatal central nervous system infection with varicella-zoster virus in renal transplant recipients. Transplantation 1984; 37: 366-368
4. Arness T, Pedersen R, Dierkhising R et al. Varicella zoster virus-associated disease in adult kidney transplant recipients: incidence and risk-factor analysis. Transpl Infect Dis 2008; 10: 260-268
5. Gourishankar S, McDermid JC, Jhangri GS et al. Herpes zoster infection following solid organ transplantation: incidence, risk factors and outcomes in the current immunosuppressive era. Am J Transplant 2004; 4: 108-115
6. Gilden D, Cohrs RJ, Mahalingam R et al. Varicella zoster virus vas-culopathies: diverse clinical manifestations, laboratory features, pathogenesis, and treatment. Lancet Neurol 2009; 8: 731-740
7. Otani N, Baba K, Okuno T. Interferon-gamma release assay: a simple method for detection of varicella-zoster virus-specific cell-mediated immunity. J Immunol Methods 2009; 351: 71-74
8. Kato S, Chmielewski M, Honda H et al. Aspects of immune dysfunction in end-stage renal disease. Clin J Am Soc Nephrol 2008; 3: 1526-1533
9. Litjens NH, Huisman M, van den DM et al. Impaired immune responses and antigen-specific memory CD4+ T cells in hemodialysis patients. J Am Soc Nephrol 2008; 19: 1483-1490
10. Kasiske BL, Zeier MG, Craig JC. KDIGO clinical practice guideline for the care of kidney transplant recipients. Am J Transplant 2009; 9: S1-155
11. Zamora I, Simon JM, Da Silva ME et al. Attenuated varicella virus vaccine in children with renal transplants. Pediatr Nephrol 1994; 8: 190-192
12. Weinberg A, Horslen SP, Kaufman SS et al. Safety and immunogen-icity of varicella-zoster virus vaccine in pediatric liver and intestine transplant recipients. Am J Transplant 2006; 6: 565-568
13. Erard V, Guthrie KA, Varley C et al. One-year acyclovir prophylaxis for preventing varicella-zoster virus disease after hematopoietic cell transplantation: no evidence of rebound varicella-zoster virus disease after drug discontinuation. Blood 2007; 110: 3071-3077